Identification of Molecular Targets and Underlying Mechanisms of Fuzheng Shengbai Decoction Against Colon Cancer Based on Network Pharmacology

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2024 Oct 14

PMID 39398618

Authors

Yu Wang

Shuiming Wang

Min Li

Qijia Zhang

Mingzhi Fang

Qin Zheng

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the molecular targets and underlying mechanisms of Fuzheng Shengbai Decoction (FZSBD) against colon cancer (CC).

Methods: Multiple network pharmacology approaches were used to predict the molecular targets and underlying mechanisms of FZSBD against CC. The expression of potential molecular targets was determined. The effects of FZSBD on cell viability, proliferation, migration, invasion, and the cell cycle of CC cells were investigated. The therapeutic efficacy, hematological, immunological, and inflammatory data in patients with CC were evaluated after treatment with the XELOX regimen with and without FZSBD.

Results: A total of 912 potential targets in FZSBD and 2765 DEGs in CC specimens were screened. Five hub genes (TP53, MYC, VEGFA, CCND1, and IL1B) closely associated with immune-related signaling pathways and the cell cycle process were identified. The five hub genes were of prognostic value in CC. The gene and protein expression of the five hub genes was significantly higher in CC tumor tissue samples than that of normal tissue samples. Furthermore, with increasing doses, FZSBD increasingly inhibited growth, migration, and invasion, and suppressed the cell cycle process of CC cells. Supplementing of FZSBD to the XELOX regimen enhanced immune modulation and alleviated inflammatory responses.

Conclusions: This study identified the molecular targets and underlying mechanisms of FZSBD treatment against CC and may provide clues for future research on the treatment of CC with FZSBD.

References

Xin T, Zhang F, Jiang Q, Chen C, Huang D, Li Y . The inhibitory effect of a polysaccharide from Codonopsis pilosula on tumor growth and metastasis in vitro. Int J Biol Macromol. 2012; 51(5):788-93. DOI: 10.1016/j.ijbiomac.2012.07.019. View

Zhang G, Guo F, Zeng M, Wang Z, Qin F, Chen J . The immune-enhancing effect and in vitro antioxidant ability of different fractions separated from Colla corii asini. J Food Biochem. 2022; 46(11):e14174. DOI: 10.1111/jfbc.14174. View

Kim J, Kim H, Hong S, Shin S, Kim Y, Kim N . A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model. Biomed Pharmacother. 2019; 116:108987. DOI: 10.1016/j.biopha.2019.108987. View

Chen X, Li W, Xiao X, Zhang L, Liu C . Phytochemical and pharmacological studies on Radix Angelica sinensis. Chin J Nat Med. 2013; 11(6):577-87. DOI: 10.1016/S1875-5364(13)60067-9. View

Qin J, Wang W, Sha L, Ge L . Huangqi Fuzheng decoction exerts antitumor activity by inhibiting cell growth and inducing cell death in osteosarcoma. Biomed Pharmacother. 2019; 114:108854. DOI: 10.1016/j.biopha.2019.108854. View

Yue Q, Zhang W, Lin S, Zheng T, Hou Y, Zhang Y . Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NFκB regulating NLRP3 inflammasome and mitochondrial ROS. Biomed Pharmacother. 2022; 152:113275. DOI: 10.1016/j.biopha.2022.113275. View

Blagih J, Buck M, Vousden K . p53, cancer and the immune response. J Cell Sci. 2020; 133(5). DOI: 10.1242/jcs.237453. View

Wu M, Huang Y, Xu H, Xie Y, Zhang T, Ma Z . [Herbalogical study on Cervi Colla]. Zhongguo Zhong Yao Za Zhi. 2020; 45(5):1188-1193. DOI: 10.19540/j.cnki.cjcmm.20200105.102. View

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

10.

Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi R, Corcione F . Worldwide burden of colorectal cancer: a review. Updates Surg. 2016; 68(1):7-11. DOI: 10.1007/s13304-016-0359-y. View

11.

Xu W, Li B, Xu M, Yang T, Hao X . Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother. 2021; 146:112542. DOI: 10.1016/j.biopha.2021.112542. View

12.

Han A, Lee Y, Kwon S, Lee H, Lee K, Seol G . Codonopsis lanceolata extract prevents hypertension in rats. Phytomedicine. 2018; 39:119-124. DOI: 10.1016/j.phymed.2017.12.028. View

13.

Peng W, Zhang S, Zhang Z, Xu P, Mao D, Huang S . Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway. J Ethnopharmacol. 2018; 224:140-148. DOI: 10.1016/j.jep.2018.05.039. View

14.

Chen X, Li Q, Kan X, Wang Y, Li Y, Yang Q . Extract of Caulis Spatholobi, a novel blocker targeting tumor cell‑induced platelet aggregation, inhibits breast cancer metastasis. Oncol Rep. 2016; 36(6):3215-3224. DOI: 10.3892/or.2016.5184. View

15.

Bent R, Moll L, Grabbe S, Bros M . Interleukin-1 Beta-A Friend or Foe in Malignancies?. Int J Mol Sci. 2018; 19(8). PMC: 6121377. DOI: 10.3390/ijms19082155. View

16.

Lin F, Zhang G, Yang X, Wang M, Wang R, Wan M . A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling.... J Ethnopharmacol. 2022; 303:115933. DOI: 10.1016/j.jep.2022.115933. View

17.

Yue J, Zhang S, Zheng B, Raza F, Luo Z, Li X . Efficacy and Mechanism of Active Fractions in Fruit of Lour. for Gastric Cancer. J Cancer. 2021; 12(20):5991-5998. PMC: 8425199. DOI: 10.7150/jca.61310. View

18.

Feng S, Zhao B, Zhan X, Motanyane R, Wang S, Li A . Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation. Drug Des Devel Ther. 2021; 15:705-720. PMC: 7917330. DOI: 10.2147/DDDT.S293046. View

19.

Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J . HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 2020; 49(D1):D1197-D1206. PMC: 7779036. DOI: 10.1093/nar/gkaa1063. View

20.

Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L . YYFZBJS ameliorates colorectal cancer progression in Apc mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal. 2020; 18(1):113. PMC: 7367414. DOI: 10.1186/s12964-020-00596-9. View